ketoconazole has been researched along with cytosine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodet, CA; Drutz, DJ; Jorgensen, JH | 1 |
| Ho, NK | 1 |
| Lefrock, JL; Smith, BR | 1 |
| Anagnostopoulos, C; Lerner, SA; Resnekov, L; Samelson, LE | 1 |
| Högl, F; Raab, W | 1 |
| Beggs, WH; Sarosi, GA | 1 |
| Durack, DT; Perfect, JR | 1 |
| Odds, FC | 1 |
| Roselle, GA; Warth, P | 1 |
| Ahearn, DG; McGlohn, MS | 1 |
| Craven, PC; Graybill, JR | 1 |
11 other study(ies) available for ketoconazole and cytosine
| Article | Year |
|---|---|
Simplified bioassay method for measurement of flucytosine or ketoconazole.
Topics: Amphotericin B; Biological Assay; Candida; Cytosine; Flucytosine; Humans; Ketoconazole | 1985 |
Systemic candidiasis in premature infants experience with drug treatment.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Miconazole | 1985 |
Effective systemic antifungal agents.
Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Half-Life; Humans; Infusions, Parenteral; Ketoconazole; Miconazole; Mycoses | 1984 |
Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Imidazoles; Ketoconazole; Mitral Valve; Piperazines; Recurrence | 1980 |
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cytosine; Drug Interactions; Econazole; Flucytosine; Imidazoles; Ketoconazole; Nystatin; Piperazines; Saccharomyces cerevisiae | 1981 |
Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
Topics: Antifungal Agents; Candida; Cytosine; Drug Resistance; Drug Synergism; Flucytosine; Imidazoles; Ketoconazole; Piperazines; Yeasts | 1982 |
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Meningitis; Piperazines; Rabbits | 1982 |
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Piperazines | 1982 |
Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
Topics: Candida; Cytosine; Drug Interactions; Flucytosine; Ketoconazole; Microbial Sensitivity Tests | 1983 |
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Topics: Amphotericin B; Candida; Culture Media; Cytosine; Drug Synergism; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Sucrose | 1984 |
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred BALB C | 1984 |